Industrials
Live Price
Offline$2.20
+0.00% today
1Y Change
+29.41%
Window
Jun 25, 2025 โ Jun 15, 2026
Coverage: 244 bars ยท Jun 25, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
BioRem Inc. (BIRMF) is a Industrials stock with a market cap of $50.00M. The stock last traded around $2.20 and up 29.4% across the available one-year price window (Jun 25, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of +13.1%, EPS growth of +57.9%, a dividend yield of 0.0%. What stands out right now is revenue +13.1%, EPS +57.9%, free cash flow +119.3% with operating margin 15.6% and ROIC 28.3%. Valuation is more restrained than many high-expectation growth names at P/E 11.4 and price/sales 1.3. Stock Foundry combines BIRMF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Industrials peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+13.1% vs +6.8% peer median
Operating Margin
Near sector median
+15.6% vs +16.9% peer median
P/E
Below sector median
11.4 vs 36.7 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 16, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +13.1% and EPS at +57.9%, with operating margin around 15.6%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +11.9% over the next 5 trading days and finished higher after 3 of those reports.
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 16, 2026 | โ | +4.4% | +20.3% | +40.7% |
2026 Mar 31, 2026 | โ | +0.0% | +2.3% | +36.0% |
2025 Nov 17, 2025 | +10.5% | +8.1% | +13.1% | +18.7% |
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
BIRMF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
BIRMF Max Drawdown
-24.72%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for BIRMF and SPY.
Company Overview
BioRem Inc.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.